Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05029999
Title CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Texas Southwestern Medical Center
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Chicago Comprehensive Cancer Center RECRUITING Chicago Illinois 60637 United States Details
Johns Hopkins University RECRUITING Baltimore Maryland 21287 United States Details
University of North Carolina RECRUITING Chapel Hill North Carolina 27599 United States Details
Sarah Cannon Research Institute WITHDRAWN Nashville Tennessee 37203 United States Details
Texas Oncology, P.A. RECRUITING Dallas Texas 75251 United States Details
UT Southwestern Medical Center RECRUITING Dallas Texas 75390 United States Details
The University of Texas Health Science Center at San Antonio RECRUITING San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field